Need professional-grade analysis? Visit stockanalysis.com
$65.33M
N/A
N/A
N/A
RHYTHM Biosciences Ltd (RHY) trades on Australian Securities Exchange in AUD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at AUD0.17, down 10.53% from the previous close.
Over the past year, RHY has traded between a low of AUD0.05 and a high of AUD0.26. The stock has gained 126.7% over this period. It is currently 33.3% below its 52-week high.
RHYTHM Biosciences Ltd has a market capitalization of $65.33M.
Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States. It offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development. The company was incorporated in 2017 and is headquartered in Parkville, Australia.
Side-by-side comparison against top Healthcare peers.